Hemophilia C via the F11 Gene
Use
This test is intended for individuals with relevant features who have a clinical or suspected diagnosis of Hemophilia C. It is also suitable for reproductive partners of individuals with a known pathogenic variant in the F11 gene. The test helps in diagnosing and managing Hemophilia C by identifying genetic variants in the F11 gene.
Special Instructions
To order the test, use the order options provided on the PreventionGenetics website or the Test Requisition Form. STAT testing is available with an additional surcharge for faster results. Ensure proper specimen collection and include relevant clinical information for accurate interpretation.
Limitations
This test focuses solely on the F11 gene and may not detect all genetic variants associated with Hemophilia C or other bleeding disorders. The test has not been cleared or approved by the FDA and is not New York state approved. Test performance is validated under CAP and CLIA regulations.
Methodology
NGS (Targeted)
Biomarkers
Result Turnaround Time
2-3 weeks
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided